CLINICAL ROLE -
Clinical Overview: Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Mavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Read More